Extracting medicinal chemistry intuition via preference machine learning
Open Access
- 31 October 2023
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-10
Abstract
The lead optimization process in drug discovery campaigns is an arduous endeavour where the input of many medicinal chemists is weighed in order to reach a desired molecular property profile. Building the expertise to successfully drive such projects collaboratively is a very time-consuming process that typically spans many years within a chemist’s career. In this work we aim to replicate this process by applying artificial intelligence learning-to-rank techniques on feedback that was obtained from 35 chemists at Novartis over the course of several months. We exemplify the usefulness of the learned proxies in routine tasks such as compound prioritization, motif rationalization, and biased de novo drug design. Annotated response data is provided, and developed models and code made available through a permissive open-source license.Keywords
This publication has 54 references indexed in Scilit:
- Inside the Mind of a Medicinal Chemist: The Role of Human Bias in Compound Prioritization during Drug DiscoveryPLOS ONE, 2012
- Enumeration of 166 Billion Organic Small Molecules in the Chemical Universe Database GDB-17Journal of Chemical Information and Modeling, 2012
- Quantifying the chemical beauty of drugsNature Chemistry, 2012
- Open Babel: An open chemical toolboxJournal of Cheminformatics, 2011
- ChEMBL: a large-scale bioactivity database for drug discoveryNucleic Acids Research, 2011
- How well do medicinal chemists learn from experience?Drug Discovery Today, 2011
- Extraneous factors in judicial decisionsProceedings of the National Academy of Sciences, 2011
- CurlySMILES: a chemical language to customize and annotate encodings of molecular and nanodevice structuresJournal of Cheminformatics, 2011
- Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributionsJournal of Cheminformatics, 2009
- The influence of drug-like concepts on decision-making in medicinal chemistryNature Reviews Drug Discovery, 2007